No paralogue variants have been mapped to residue 3983 for RYR1.
RYR1 | AMSVAKQVFNSLTEYIQGPCTGNQQSLAHS>R<LWDAVVGFLHVFAHMMMKLAQDSSQIELLK | 4013 |
RYR2 | AIQVAKQVFNTLTEYIQGPCTGNQQSLAHS>R<LWDAVVGFLHVFAHMQMKLSQDSSQIELLK | 3969 |
RYR3 | ALAVTKQIFNSLTEYIQGPCIGNQQSLAHS>R<LWDAVVGFLHVFANMQMKLSQDSSQIELLK | 3865 |
cons | > < |
Protein | CDS | Disease Classification | Disease | dbSNP links | Effect Prediction |
---|---|---|---|---|---|
p.R3983H | c.11948G>A | Other Myopathy | SIFT: Polyphen: | ||
Reports | Other Myopathy | Administration of ondansetron is associated with lethal outcome. Pediatrics. 2010 125(6):e1514-7. 20439600 | |||
p.R3983C | c.11947C>T | Other Myopathy | SIFT: Polyphen: | ||
Reports | Other Myopathy | Identical de novo mutation in the type 1 ryanodine receptor gene associated with fatal, stress-induced malignant hyperthermia in two unrelated families. Anesthesiology. 2011 115(5):938-45. 21918424 |